The Role of Bronchoscopic Interventions in the Management of Pneumothorax in Interstitial Lung Disease.
The Role of Bronchoscopic Interventions in the Management of Pneumothorax in Interstitial Lung Disease.
复制标题
DOI:
10.1097/lbr.0000000000000731
复制
发表时间:
2021-07-01
影响因子:
3.3
通讯作者:
Gomez Manjarres DC
中科院分区:
文献类型:
--
作者:
Valentin R;Patel DC;Jantz MA;Mehta HJ;Mehrad B;Gomez Manjarres DC
METHODSAfter institutional approval (IRB201801716), we performed a single center retrospective analysis of all patients with a diagnosis of ILD and secondary pneumothorax admitted to the University of Florida Health-Shands Hospital from October 1, 2012 to June 30, 2019 who underwent bronchoscopic intervention as part of the management of persistent air leak. Spiration valve system (Olympus Inc., Center Valley, PA) and synthetic hydrogel CoSeal (US Baxter International Inc., Deerfield, IL) were used for the study. Persistent air leak was defined as air leak after chest tube insertion lasting> 48 hours, or> 24 hours after first intervention. Primary endpoint was treatment success defined as chest-tube removal without recurrence of pneumothorax during the same hospitalization. Secondary endpoints were recurrence of pneumothorax and procedural complications including major complications, that is death and acute hypoxic respiratory failure, and minor complications as valve displacement or migration. Data were analyzed in Prism (version 8 for Mac, GraphPad, San Diego, CA). All variables were analyzed using descriptive statistics.RESULTSWe identified 14 patients with ILD and secondary pneumothorax who were hospitalized 16 times (total of 16 encounters) over the study period (Table 1). The first intervention was a pleural procedure in 4 encounters, and a bronchoscopic procedure in 12 encounters. Among the encounters that underwent initial pleural intervention, all required subsequent bronchoscopic procedure to achieve air leak resolution, and among the encounters with initial bronchoscopic intervention 8 (67%) required additional either bronchoscopic or pleural intervention (Fig. 1). A total of 40 endobronchial valves were deployed with a median of 3 valves per procedure (interquartile range: 2 to 5), and a total of 19 hydrogel applications were performed with a median of 2 applications (interquartile range: 1 to 3) per procedure.